Amneal gets expanded insurance coverage for its Parkinson???s disease treatment

Neuron system disease

koto_feja

Amneal Pharmaceuticals (AMRX) announced Thursday that insurance coverage accounts, the Veterans Administration, UnitedHealthcare (NYSE:UNH) and CVS Health (NYSE:CVS), have added Crexont extended-release capsules for Parkinson???s disease treatment to their national prescription drug formularies.

The New Jersey based biopharma company said

Leave a Reply

Your email address will not be published. Required fields are marked *